Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus

Código QR

Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus

BACKGROUND: Current studies investigated diseases associated with testosterone (T) deficiency; however, data on the combination of non-alcoholic fatty liver disease (NAFLD) with hypogonadism and diabetes mellitus (DM) in men are extremely limited. AIMS: To evaluate the effects of hypogonadism on th...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Irina A. Khripun, Sergey V. Vorobyev, Yanina Allahverdieva
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2019
Materias:	hypogonadism testosterone diabetes mellitus nonalcoholic fatty liver disease liver androgen deficiency Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/dec8d163fa594190bd6648a631d7058a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
por: Galina Afanas'evna Melnichenko, et al.
Publicado: (2017)

Association of insulin resistance and non-alcoholic fatty liver disease
por: Ekaterina E. Mishina, et al.
Publicado: (2021)

The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
por: Galina A. Melnichenko, et al.
Publicado: (2019)

The clinical and epidemiological characteristics of hypogonadism in men with type 2 diabetes mellitus
por: Galina A. Mel'nichenko, et al.
Publicado: (2019)

Association of the polymorphism in the androgen receptor gene and endothelial function in men with type 2 diabetes
por: Irina Alekseevna Khripun, et al.
Publicado: (2015)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
por: Apollinariya V. Bogolyubova, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
por: Ekaterina E. Mishina, et al.
Publicado: (2017)

Association between hypogonadism and reproductive tissue steroid-producing cells antibody in men with positive MAR test IgG and diabetes mellitus type 1
por: Roman V. Rozhivanov, et al.
Publicado: (2019)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
por: Jin Feng, et al.
Publicado: (2021)

Hormonal and metabolic characteristic of androgen deficiency and its correction by testosterone in men with type 1 diabetes mellitusundergoing programmed hemodialysis
por: Alexander Evgen'evich Lepetukhin, et al.
Publicado: (2010)

Age-related hypogonadism in men with metabolic syndrome
por: Yulia Alexandrovna Tishova, et al.
Publicado: (2010)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
por: Gwyneth Shook Ting Soon, et al.
Publicado: (2021)

Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
por: Filip R, et al.
Publicado: (2018)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
por: Evgenia Pavlovna Kosobyan, et al.
Publicado: (2010)

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease
por: Xiaojiaoyang Li, et al.
Publicado: (2021)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
por: T. E. Promenasheva, et al.
Publicado: (2014)

Analysis of prevalence of risk factor of nonalcoholic fatty liver disease in the Buryat Republic
por: E. G. Naydanova
Publicado: (2015)

Cognitive effects of testosterone and finasteride administration in older hypogonadal men
por: Borst SE, et al.
Publicado: (2014)

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
por: Shahinul Alam, et al.
Publicado: (2021)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
por: A. V. Bogolyubova, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease (NAFLD) – a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients
por: Mikolasevic I, et al.
Publicado: (2014)

PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD
por: Norio Akuta, et al.
Publicado: (2021)

d-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study
por: Maurizio Nordio, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks
por: Cheung A, et al.
Publicado: (2021)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao YQ, et al.
Publicado: (2016)

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
por: Huang J, et al.
Publicado: (2021)

Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan
por: Shen HC, et al.
Publicado: (2014)

Association Between the Triglyceride–Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study
por: Liu J, et al.
Publicado: (2021)

Comparación de distintos métodos para evaluar la función androgénica en el adulto mayor
por: Campusano M,Claudia, et al.
Publicado: (2006)

Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
por: Fan Y, et al.
Publicado: (2021)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
por: Soleimani D, et al.
Publicado: (2020)

Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter
por: Gandha N, et al.
Publicado: (2020)

Association Between Low Serum Testosterone and the Development of Metabolic Syndrome in Elderly Taiwanese Men
por: Zhong SR, et al.
Publicado: (2021)

Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted <sup>1</sup>H-NMR Metabolomics
por: Emma J. Robinson, et al.
Publicado: (2021)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Masahiro Matsui, et al.
Publicado: (2021)

Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
por: Ye Lu, et al.
Publicado: (2021)

Effects of DHA dietary intervention on hepatic lipid metabolism in apolipoprotein E-deficient and C57BL/6J wild-type mice
por: Jingjing Xu, et al.
Publicado: (2021)

Polyphenols-rich extracts from walnut green husk prevent non-alcoholic fatty liver disease, vascular endothelial dysfunction and colon tissue damage in rats induced by high-fat diet
por: Guoliang Wang, et al.
Publicado: (2021)

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
por: Kishore M Lakshman, et al.
Publicado: (2009)

Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach
por: Yang T, et al.
Publicado: (2021)